The significantly reduced expression of activating receptor NKG2D on NK cells isolated from PBMC and tumor tissue is demonstrated in patients with gastric cancer [39], CRC [40], and HCC [41]. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.